Biogen Presents Additional Salanersen Data Showing New Motor Milestones Achieved in Children with SMA Previously Treated with Gene Therapy

New Phase 1b data support the safety and effectiveness of salanersen over one year in children with SMA who had the potential for improvement due to suboptimal clinical status with prior gene therapy Salanersen is a novel antisense oligonucleotide and has the potential to deliver high efficacy in SMA with once-yearly dosing Biogen also debuted […]


8 h.
Science
ID: 5636344227987295423


Similar News expand_more


Science
Science
Science
Science
Technology
Science
Science
Science
Science
Science
Technology
Science
Science
Science
Science
Science
Technology
Science
Science
Science
Technology
Science
Science
Science
Technology
Science
Technology
Science
Technology
Science
Science
Education
Sport
Crime
Science
Science
Science
Science
Education
Science
Science
Science
Science
Science
Education
Science
Science
Science
Science
Popular countries based on strong economic and political relations

Add Watch Country

arrow_drop_down